Palisade bio to present at digestive disease week (ddw) 2024

Carlsbad, ca, feb. 15, 2024 (globe newswire) -- palisade bio, inc.  (nasdaq: pali) (“palisade” or the “company”), a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal (gi) diseases, today announced that its abstract has been accepted for poster presentation at ddw 2024 being held in washington, d.c., may 18-21, 2024.
PALI Ratings Summary
PALI Quant Ranking